... among which leading international pharma are actively licensing in Chinese innovative assets
Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · page 44 of 58
The slide highlights the trend of international pharma companies licensing innovative assets from Chinese biotech firms.
Consulting deck · client_example · illustrate_case · balanced density
Slide locked Sign in to view
Slide schematic 5/5
callout 1/1 source-note 1/1 table 1/1 title 2/2
Components 5
primary source-note data action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 1
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.